<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PHIO
Phio Pharmaceuticals
$
()


  • Phio Pharmaceuticals announces upcoming presentation on PH-762 at ASCGT

    4/11/2024 - 07:33am
  • Phio Pharmaceuticals says INTASYL platform to be focus of 'Viewpoint'

    4/3/2024 - 07:35am
  • Phio Pharmaceuticals reports FY23 EPS ($5.20) vs ($10.10) last year

    4/2/2024 - 07:39am
  • Phio Pharmaceuticals presents data about INTASYL

    3/21/2024 - 07:40am
  • Phio announces addition of three clinical trial sites for Phase 1b study

    3/13/2024 - 14:02pm
  • Phio Pharmaceuticals announces patent grant by USPTO

    3/6/2024 - 10:34am
  • Phio Pharmaceuticals price target lowered by $2 at H.C. Wainwright, here's why

    2/6/2024 - 06:08am
  • Phio Pharmaceuticals announces new preclinical data on INTASYL

    1/31/2024 - 08:10am
  • Phio Pharmaceuticals files to sell 4.42M shares of common stock for holders

    12/19/2023 - 16:54pm
  • Biotech Alert: Searches spiking for these stocks today

    12/8/2023 - 11:05am
  • Biotech Alert: Searches spiking for these stocks today

    12/7/2023 - 11:14am
  • Phio Pharmaceuticals announces exercise of warrants for $2.8M gross proceeds

    12/7/2023 - 08:13am
  • Phio announces first U.S. patient enrolled in Phase 1b trial with PH-762

    11/9/2023 - 07:44am
  • Phio Pharmaceuticals presents preclinical data on INTASYL compound

    11/3/2023 - 12:16pm
  • Phio Pharmaceuticals presents new data of its INTASYL compound PH-894

    10/11/2023 - 07:31am
dynamic_feed Breaking News